ÂÜÀòÂÒÂ×

The Leadership Team at Mediar Therapeutics drives the strategic vision and operational excellence of the company, focusing on the development of innovative antibody-based therapies to combat fibrosis across multiple organ systems. Comprising experts in clinical operations, finance, scientific research, and antibody engineering, the team collaborates to advance preclinical initiatives, secure funding, and foster partnerships that propel the company's mission forward.